ALVO - Alvotech
3.51
-0.110 -3.134%
Share volume: 650,681
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.62
-0.11
-0.03%
Fundamental analysis
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Performance
5 Days
0 0%
1 Month
8.71%
3 Months
-28.17%
6 Months
-57.51%
1 Year
-56.54%
2 Year
-72.84%
Key data
Stock price
$3.51
DAY RANGE
$3.51 - $3.72
52 WEEK RANGE
$3.03 - $11.85
52 WEEK CHANGE
-$56.70
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-14-2025
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
N/A
Recent news